R.O. Casasnovas (France) C. Chang (USA) B. Chiu (USA) A. Delmer (France) K. Ekstrom Smedby (Sweden)...

Comité ScientifiqueScientific Committee

Access to the Faculty of Medicine7 boulevard Jeanne d'Arc - Dijon

Joint meeting

2013 InterLymph Symposium

2e Journée d’Epidémiologie des Hémopathies Malignes

Lymphoma aetiology and prognosis,

the role of environment and genetic susceptibility

June 24- 26, 2013

Dijon, France

Airport Dijon-Bourgogne Regular flights from Bordeaux, Toulouse, Nantes, Nevers…

Train - TramwayFrom the Railway station Dijon Ville : take Line1 to "Quetigny", stop at "CHU-Hôpitaux".

CarWhen arrivieng in Dijon, follow « DIJON Université ».

TaxiDijon Taxi, call center : 03 80 41 41 12

Partenaires

2013 InterLymph Symposium2e Journée d’Epidémiologie des Hémopathies Malignes

Lymphoma aetiology and prognosis, the role of environment and genetic susceptibility

9:00 Registration

9:45 Welcome (M Maynadié)

10:00-11:30 Latest findings from the InterLymph Consortium [chairs : S Wang – X Troussard]10:00-10:20 Comparison of risk factors for all subtypes (L Morton) 10:20-10:40 Key risk factors for rarer B-cell subtypes (A Monnereau/P Bracci)10:40-11:00 Genome-wide association study (GWAS) of non-Hodgkin lymphoma subtypes : an overview (N Rothman) 11:00-11:20 Interaction between autoimmune disease and immune polymorphisms in risk of non-Hodgkin lymphoma (S Wang) 11:20-11:30 Discussion

11:30-12:00 Coffee break / Morning tea / Poster session

12:00-01:30 Lymphoma and Survival [chairs : K Ekstrom-Smedby – T Lamy]12:00-12:20 Survival of lymphoma in Europe (M Sant)12:20-12:40 Lifestyle factors and non-Hodgkin lymphoma survival (A Seniori)12:40-01:00 Prognostic Factors in Lymphoma: Can observational epidemiology studies get the same answers as RCTs? (J Cerhan)01:00-01:20 Germline genetic variation and lymphoma outcomes (H Ghesquieres)01:20-01:30 Discussion

01:30-02:20 Lunch

02:20-03:00 Hodgkin Lymphoma [chairs : S Slager - RO Casasnovas]02:20-02:40 Risk factors for Classical Hodgkin lymphoma (H Hjalgrim)02:40-03:00 Meta analysis of the GWAS strategy in Hodgkin lymphoma (W Cozen)

03:00-03:20 Defining a Predictive Blood Biomarker for Follicular Lymphoma (B Nadel)

03:20-03:30 Discussion

03:30-04:00 Coffee break / Afternoon tea / Poster session

04:00-05:30 Round table: Second cancer in lymphoid malignancies [chairs : L. Morton – G Salles]04:00-04:20 K2-France Project (J Jégu)04:20-04:40 K2-France: second cancer in Follicular Lymphoma and in DLBCL (C Rossi)04:40-05:00 Second cancer in Follicular Lymphoma included in clinical trials (C Thieblemont)05:00-05:20 K2-France: second cancer in CLL (X Troussard)05:20-05:30 Discussion

05:30 Wrap-up (M Maynadié)

7:30-8:00 On-site Registration

8:00-10:00 Pathology /Survival working group meeting

Subtypes Initiative

10:00-10:30 Coffee break / Morning tea

10:30-012:30 Immunology and Infection working group

12:30-02:00 Lunch

Group photo

02:00-04:00 Lifestyle and Environment working group

04:00-04:30 Coffee break/Afternoon tea

04:30-06:30 GWAS Initiative

06:30 Dinner

8:00-9:40 Hodgkin Lymphoma Working Group

9:40-10:00 Coffee break / Morning tea

10:00-12:00 Hodgkin Lymphoma Working Group

12:00-01:00 Working Lunch

INTERLYMPH Business meeting

01:00-02:00 Family studies working group

02:00-03:00 International Multiple Myeloma Consortium

03:00-03:20 Coffee break/Afternoon tea

03:20-06:00 International Multiple Myeloma Consortium

June 24, 2013 June 25, 2013 June 26, 2013